Medicine and Dentistry
Age
19%
Analysis
17%
Biochemical Recurrence
5%
Biopsy
14%
Bladder
21%
Bladder Cancer
11%
Bone Morphogenetic Protein
9%
Bone Morphogenetic Protein 6
10%
Bone Morphogenetic Protein Receptor 2
8%
Cancer Tissue
6%
Cells
7%
Combination Therapy
5%
Continence
9%
Cystectomy
29%
Diagnosis
10%
Differentiation
6%
Experience
7%
Fat Pad
6%
Follow up
8%
Gleason Score
9%
Incidence
14%
Inpatient
32%
Lower Urinary Tract Symptom
12%
Lymph Node
5%
Man
47%
Marker
13%
Metastatic Carcinoma
5%
Neobladder
22%
Neoplasm
17%
Patient
100%
Prostate
5%
Prostate Cancer
43%
Prostate Hypertrophy
12%
Prostate Specific Antigen
30%
Prostatectomy
7%
Prostatitis
5%
Recurrent Disease
8%
Retrospective Cohort Study
10%
Retrospective Study
6%
Robot-Assisted Prostatectomy
33%
Serum
17%
Specimen
11%
Surgery
8%
Surgical Margin
7%
Surveillance
10%
Symptom
14%
Telomerase
10%
Transitional Cell Carcinoma
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
5%
Alpha Adrenergic Receptor Blocking Agent
5%
Antibiotic Agent
7%
Antihypertensive Agent
8%
Blindness
8%
Cohort Study
6%
Erectile Dysfunction
8%
Escherichia coli
6%
Hypertension
8%
Neoplasm
8%
Premature Ejaculation
8%
Programmed Death 1 Ligand 1
8%
Prostate Cancer
6%
Prostatitis
8%
Sildenafil
8%
Symptom
11%
Biochemistry, Genetics and Molecular Biology
Association
6%
Bone Morphogenetic Protein
12%
Bone Morphogenetic Protein Receptor Type 2
8%
Cancer Cell
7%
Dose
6%
Escherichia coli
8%
Gleason Score
5%
Growth
5%
Growth Factor Receptor
6%
Lipopolysaccharide
8%
Liquid
5%
Membrane
5%
Nested Gene
7%
Sample
8%
Transforming Growth Factor
6%